Streetbeat News

FUJIY

Fujifilm Holdings Corp.

https://www.fujifilmholdings.com/ja/

CEO

Shigetaka Komori

Open

10.79

Mkt cap

26B

Volume

544

High

10.79

P/E Ratio

51.29

52-wk high

13.88

Low

10.77

Div yield

0.01

52-wk low

9.34

FUJIFILM Diosynth Biotechnologies has completed the expansion of its California cell therapy facility and received EMA GMP certification.

Portfolio Pulse from

November 20, 2024 | 10:00 pm

FUJIFILM Healthcare Europe has launched the next stage of DeepInsight, an innovative ultrasound technology aimed at improving early diagnosis and treatment. This advancement is expected to benefit imaging professionals by enhancing accuracy and follow-up management.

Portfolio Pulse from

November 09, 2024 | 9:15 am

FUJIFILM reported a decline in earnings for Q2, but revenues increased year-over-year due to strong sales in the Imaging and Electronics segments and favorable exchange rates.

Portfolio Pulse from

November 07, 2024 | 5:45 pm

FUJIFILM Diosynth Biotechnologies has announced the launch of the first phase of its global CDMO ecosystem expansion, focusing on a modular network for facility design and drug production.

Portfolio Pulse from

November 05, 2024 | 12:30 pm

All corporate logos and prices are for illustrative purposes only and are not a recommendation, an offer to sell, or a solicitation of an offer to buy any security.